FOXP1 suppresses immune response signatures and MHC class II expression in activated B-cell-like diffuse large B-cell lymphomas
P. Brown(University of Oxford), Alison H. Banham(University of Oxford)
Cited by 67
Related Papers
CRISPR/Cas9-Mediated Foxp1 Silencing Restores Immune Surveillance in an Immunocompetent A20 Lymphoma Model
|Frontiers in Oncology|2020|39